Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Valion Bio (TIVC) Net Cash Flow (2021 - 2025)

Valion Bio has reported Net Cash Flow over the past 5 years, most recently at $9.2 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 6354.42% year-over-year to $9.2 million; the TTM value through Dec 2025 reached $10.6 million, up 863.96%, while the annual FY2025 figure was $10.6 million, 863.96% up from the prior year.
  • Net Cash Flow for Q4 2025 was $9.2 million at Valion Bio, up from $2.2 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $12.1 million in Q4 2021 and troughed at -$2.8 million in Q4 2022.
  • A 5-year average of $577200.0 and a median of -$609500.0 in 2021 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: crashed 396.85% in 2022 and later skyrocketed 6354.42% in 2025.
  • Year by year, Net Cash Flow stood at $12.1 million in 2021, then tumbled by 123.18% to -$2.8 million in 2022, then surged by 36.89% to -$1.8 million in 2023, then soared by 91.71% to -$147000.0 in 2024, then skyrocketed by 6354.42% to $9.2 million in 2025.
  • Business Quant data shows Net Cash Flow for TIVC at $9.2 million in Q4 2025, $2.2 million in Q3 2025, and $531000.0 in Q2 2025.